The Drug Control Authority (DCA) has approved Merck’s molnupiravir for Covid-19 treatment yesterday, making it the second antiviral pill to be approved in Malaysia for treating the disease.

The DCA previously granted provisional approval for Pfizer’s Paxlovid (a pill consisting of nirmatrelvir and ritonavir) in March. 

Both drugs are meant to be administered during the early phases of a Covid-19 infection to reduce...